Jin Qian Cao

Lysimachia christinae Hance

Also known as: Gold Coin Grass(English) 金钱草(Chinese)

Geumjeoncho金錢草 금전초 Chin Ch'ien Ts'ao

Updated October 5, 2026 · Not yet clinically reviewed

Jin Qian Cao
Photo: 阿橋 HQ, CC BY-SA 2.0, via Wikimedia Commons

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
transforming dampness
Temperature
Cool
Taste
Sweet,Salty,Bland
Channels
Liver,Gallbladder,Kidney

Functions

Clears Damp-Heat and Resolves Jaundice; Promotes Urination and Relieves Stranguria; Expels Urinary Stones; Clears Heat and Resolves Toxicity; Reduces swelling

Traditional uses

Jin Qian Cao (gold coin grass, lysimachia) is a cold herb with a strong affinity for the Liver and Gallbladder, where it clears Damp-Heat and promotes the expulsion of stones. It is widely used for gallstones and kidney stones, as well as the jaundice and urinary pain associated with stone-related Damp-Heat obstruction. Its drainage of Damp and Heat also extends to treating painful, difficult urination and damp-type skin conditions.

Western herbalism

Properties: diuretic, anti-inflammatory, hepatic

Pharmacological effects

  • Choleretic lithagogic: Oral 1:1 decoction for 6 weeks raised bile secretion and excretion in rats; duodenal drainage in humans showed choleresis; a Lithagogue Decoction based on the herb raised bile flow 3-20 fold in anesthetized dogs, reduced bile concretion components and relaxed Oddi's sphincter.
  • Diuretic lithagogic: Intraduodenal decoction (120 g herb) in anesthetized dogs increased ureteral peristalsis and urine output, similar to hydrochlorothiazide; oral herb reported to acidify urine, aiding dissolution of stones formed in alkaline conditions.
  • Cardiovascular / cholesterol: Precipitated euglobulin of dog blood and was anticoagulant in vitro; enhanced hepatic bile secretion and probably accelerated cholesterol excretion in man.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 327.

Formulas using this herb

5 of 5 formulas

Botanical

Lysimachia christinae is a creeping perennial herb in the Primulaceae family, native to central and southern China and parts of Vietnam. The slender, often reddish stems trail along the ground and root at the nodes, reaching 20-60 cm in length. The opposite leaves are broadly ovate to nearly orbicular, 1.5-4 cm across, with entire margins, short petioles, and conspicuous translucent dotted glands when held to the light. Solitary yellow flowers are borne in the leaf axils on slender pedicels in late spring and summer; they are five-lobed, funnel-shaped, and about 1-1.5 cm across. The fruit is a small dehiscent capsule containing many seeds. In TCM, the whole flowering plant (Jin Qian Cao) is harvested in summer and used as a sweet, salty, slightly cold herb to clear damp-heat, promote urination, and dissolve stones, particularly urinary and gallbladder stones.

Family
Primulaceae
Pharmaceutical name
Herba Lysimachiae
Parts used
whole_plant
Plant type
herb
Native region
Sichuan

Constituents

Quercetin

Flavonol aglycone · Among the principal flavonoids of the aerial parts, with content varying markedly by growing region

One of the main flavonoids identified in Lysimachiae Herba by UFLC triple-TOF mass spectrometry and by UHPLC-MS/MS. It is the aglycone underlying much of the antioxidant activity of the ethanolic extract, and it and its glycosides are the compounds most often nominated in network-pharmacology analyses of the herb's anti-lithiasis effect.

Quercitrin

Flavonol glycoside, quercetin 3-O-rhamnoside · Major flavonoid glycoside of the herb

A principal glycosidic form in which the herb delivers quercetin. Flavonoid glycosides of this type dominate the polar fractions that carry the antioxidant and endothelial-protective activity of the extract.

Isoquercitrin

Flavonol glycoside, quercetin 3-O-glucoside · Characteristic flavonoid of the herb

Reported as one of the typical constituents of Lysimachia christinae alongside kaempferol and trifolin. Its abundance is one of the chemical features by which authentic material is distinguished from the Desmodium species substituted for it.

Kaempferol and its glycosides including trifolin

Flavonol and flavonol glycosides · Second major flavonol series of the herb

Kaempferol, its 3-O-galactoside trifolin and related glycosides make up the second flavonol series of the drug and contribute to its antioxidant capacity.

Rutin

Flavonol glycoside, quercetin 3-O-rutinoside · Present among the flavonoid fraction

Identified in the herb and specifically implicated as the constituent responsible for the antiproliferative effect of the extract in breast cancer cell lines, which is a laboratory observation rather than a clinical indication.

Phenolic acids

Hydroxycinnamic and hydroxybenzoic acids · Minor to moderate fraction; contributes with the flavonoids to total polyphenol content

The phenolic acid fraction accompanies the flavonoids in the polar extract, and the n-butanol fraction richest in flavonoids and phenolics showed the strongest radical-scavenging and endothelial-protective activity.

Polysaccharides

Plant polysaccharides · Water-extractable macromolecular fraction

An extractable macromolecular fraction with reported antioxidant activity in vitro. It is not a Pharmacopoeia assay target and is not the fraction to which the traditional stone-expelling action is attributed.

Drug interactions

Desmodium styracifolium (Guang Jin Qian Cao)

Moderate · Wrong species dispensed; different phytochemistry and different evidence base · Evidence level: Established

Jin Qian Cao is one of the worst pinyin collisions in the materia medica. The Chinese Pharmacopoeia species is Lysimachia christinae, family Primulaceae, but Desmodium styracifolium, family Fabaceae, is used under the same name in Guangdong and Guangxi as Guang Jin Qian Cao and has its own separate Pharmacopoeia entry and a quite different chemistry.

The substitution is not occasional. A 2025 molecular authentication study using chloroplast atpF species-specific PCR and high-resolution melting analysis tested 60 commercial samples and found an adulteration rate of 51.67 percent: only 29 samples were genuine Lysimachia christinae, 29 were Desmodium styracifolium, one was Lysimachia hemsleyana and one was Lysimachia congestiflora.

Neither species is toxic, so this is a substitution of identity rather than a poisoning hazard. Its practical consequence is that a practitioner dosing from the Lysimachia evidence base may be giving a Fabaceae herb with a different flavonoid and alkaloid profile, and that half of published clinical experience under the name may not describe the species on the label.

Clinical note: Specify the binomial when ordering, and prefer suppliers who identify to species by DNA or by a chromatographic fingerprint. Authentic Lysimachia christinae shows black or dark-brown glandular dots and streaks on leaf and calyx, visible against the light after soaking; Desmodium styracifolium is a distinct legume with trifoliate or unifoliate leaves. Do not treat published Desmodium data as evidence for this record and vice versa.

Glechoma longituba (Lian Qian Cao) and other regional Jin Qian Cao plants

Minor · Wrong species; uncharacterised substitution · Evidence level: Possible

Beyond Desmodium, at least Glechoma longituba, family Lamiaceae, is used regionally under a Jin Qian Cao name in Jiangsu, Shanghai and Anhui, and Dichondra and Hydrocotyle species carry similar names elsewhere. Glechoma is readily told apart on inspection by its square stems, kidney-shaped crenate leaves and aromatic smell when rubbed, none of which Lysimachia has.

Clinical note: Reject aromatic, square-stemmed material supplied as Jin Qian Cao. The organoleptic check is quick and effective for this particular substitution, unlike the Desmodium one.

Diuretics and antihypertensives

Theoretical · Possible additive fluid and electrolyte loss · Evidence level: Theoretical

The herb is used and described as a diuretic, and animal work reports that extracts increase ureteral peristalsis. Additive volume and electrolyte effects with loop or thiazide diuretics are a reasonable expectation, but no pharmacokinetic or pharmacodynamic interaction study exists and no case reports have been published.

Clinical note: In older patients or those on established diuretic therapy, watch fluid status and electrolytes over prolonged courses. Do not represent this as a documented interaction.

Dosage

FormAmountFrequencyNotes
decoction15–60 gDaily
中国药典 2020 【用法与用量】15~60g。 【性味与归经】甘、咸,微寒。归肝、胆、肾、膀胱经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
7

Species-specific PCR and HRM assays targeting chloroplast atpF gene enable rapid authentication of Lysimachia christinae and detection of adulteration in commercial herbal products

Wang L, Hu W, Huang Z, Zhou Z, Chen N, Li Y, Hu Y, Yang F · Industrial Crops and Products · 2025 · in vitro

In vitro / animal · Not yet verified

Developed species-specific PCR and high-resolution melting assays on a unique region of the chloroplast atpF gene, then applied them to 60 commercial Jin Qian Cao samples. The adulteration rate was 51.67 percent: 29 samples were authentic Lysimachia christinae, 29 were Desmodium styracifolium, one Lysimachia hemsleyana and one Lysimachia congestiflora.

The most consequential single finding for this record: roughly half of commercial material sold under this name is a different species.

doi:10.1016/j.indcrop.2025.121587

Lysimachia christinae Hance regresses preestablished cholesterol gallstone in mice

Deng J, Ren M, Dai X, Qu D, Yang M, Zhang T, Jiang B · Journal of Ethnopharmacology · 2015 · animal

In vitro / animal · Verified

In mice with lithogenic-diet-induced cholesterol gallstones, Lysimachia christinae reduced pre-established stones rather than merely preventing their formation, with changes in biliary cholesterol saturation.

Animal evidence for the traditional gallstone indication, using the correct species.

doi:10.1016/j.jep.2015.03.031

Evaluation of the antioxidant and endothelial protective effects of Lysimachia christinae Hance (Jin Qian Cao) extract fractions

Wu NH, Ke ZQ, Wu S, Yang XS, Chen QJ, Huang ST, Liu C · BMC Complementary and Alternative Medicine · 2018 · in vitro

In vitro / animal · Not yet verified

Fractionation study finding that the n-butanol fraction of the ethanolic extract, richest in flavonoids and phenolics, had the strongest radical-scavenging and endothelial-protective activity.

Establishes which fraction carries the antioxidant activity; it does not bear on the stone indications.

doi:10.1186/s12906-018-2157-1

Lysimachia christinae Hance aqueous extract ameliorates renal injury in kidney stone rats and calcium oxalate crystal-induced oxidative stress in HK-2 cells via inhibiting the PI3K/Akt/mTOR pathway

Zheng X, Lv S, Wang W, Zhu L, Lin L · Histology and Histopathology · 2026 · animal

In vitro / animal · Not yet verified

Aqueous extract of Lysimachia christinae improved inorganic ion handling and renal histopathological injury in a rat nephrolithiasis model, and reduced calcium oxalate crystal-induced oxidative stress in HK-2 human proximal tubule cells, with the authors attributing the effect to inhibition of PI3K/Akt/mTOR signalling.

Combined animal and cell study; no human data.

doi:10.14670/HH-18-964

Lysimachia christinae Hance Extract Mitigates Kidney Stone Formation: Association with NOX2/ROS Axis Modulation and Ferroptosis

Xia L, Zhou Z, Luo C, Yang Y, Zou D, Zhang H, Hu K, Luo X · Current Issues in Molecular Biology · 2026 · animal

In vitro / animal · Not yet verified

Reports that Lysimachia christinae extract reduced kidney stone formation in a rodent model, associating the effect with modulation of the NOX2 and reactive oxygen species axis and with ferroptosis.

Preclinical mechanism work; a second independent laboratory reaching a broadly similar oxidative-stress conclusion.

doi:10.3390/cimb48050520

Qualitative Analysis and Componential Differences of Chemical Constituents in Lysimachiae Herba from Different Habitats (Sichuan Basin) by UFLC-Triple TOF-MS/MS

Zhou Y, Chen H, Xue J, Yuan J, Cai Z, Wu N, Zou L, Yin S · Molecules · 2022 · in vitro

In vitro / animal · Not yet verified

Profiled the constituents of Lysimachiae Herba across Sichuan Basin collection sites by ultra-fast liquid chromatography with triple time-of-flight mass spectrometry, identifying flavonoids, phenolic acids, amino acids, tannins, fatty acids and coumarins, and quantifying how markedly composition varies with growing region.

Relevant to dosing consistency: the same authenticated species differs substantially in content between habitats.

doi:10.3390/molecules27144600

A Network Pharmacology Study on the Mechanisms of the Herbal Extract, Christina Loosestrife, for the Treatment of Nephrolithiasis

Yu K, Zhang P, Xie ZG · Medical Science Monitor · 2020 · in vitro

In vitro / animal · Not yet verified

Computational network-pharmacology analysis nominating candidate active compounds and targets of Lysimachia christinae in nephrolithiasis.

Hypothesis-generating only. Network pharmacology predicts targets from databases and does not test them; it carries no clinical weight on its own.

doi:10.12659/msm.919360

Safety

Contraindications

Patients with dorsal furuncle or diarrhea because spleen deficiency should avoid drinking the raw juice extracted from it by pounding.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 153–155.

Side effects

  • No side effects in 10 cholelithiasis patients given L. hemsleyana 150-250 g daily for over 6 months; no toxic reactions in one case treated 318 days; one ureteral calculi case given 500 g daily for 7 days had no adverse reactions.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 327.

Cultural and historical

Ben Cao Gang Mu Shi Yi (Supplement to the Compendium of Materia Medica), Zhao Xuemin · Qing dynasty, compiled from 1765, printed 1871

Jin Qian Cao enters the mainstream materia medica here rather than in the classical canon. It is absent from the Shen Nong Ben Cao Jing and from Li Shizhen's Ben Cao Gang Mu, which is worth knowing: this is a Qing-era folk drug taken up into formal practice, and its long classical pedigree is often overstated.

Bai Cao Jing (Mirror of the Hundred Herbs) · Qing dynasty, mid-18th century, surviving through citation in Ben Cao Gang Mu Shi Yi

Cited by Zhao Xuemin for the drug's use in swellings, sores and toxic swelling. The early record emphasises the clearing-toxicity and reducing-swelling actions as much as the stone-expelling one for which the herb is now mainly used.

Zhi Wu Ming Shi Tu Kao (Illustrated Investigation of Names and Natures of Plants), Wu Qijun · Qing dynasty, 1848

Illustrates and describes creeping herbs carried under coin-grass names. Botanical works of this period already show several unrelated plants sharing the name, which is the historical root of the modern Lysimachia, Desmodium and Glechoma confusion rather than a recent commercial development.

Chinese Pharmacopoeia (Zhonghua Renmin Gongheguo Yaodian) · Modern standard, 2010 and subsequent editions

Fixes Jin Qian Cao as the dried whole herb of Lysimachia christinae Hance and lists Guang Jin Qian Cao, Desmodium styracifolium, as a separate drug with its own monograph. The two entries are what makes the commercial substitution identifiable as substitution rather than as regional variation.

References

  1. Liu S, Luorong Q, Hu K, Cao W, Tao W, Liu H, Zhang D. Aqueous Extract of Lysimachia christinae Hance Prevents Cholesterol Gallstone in Mice by Affecting the Intestinal Microflora. Journal of Microbiology and Biotechnology. 2021 doi:10.4014/jmb.2106.06043
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice